The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia

BACKGROUND: Hypertension and dyslipidemia are major risk factors of cardiovascular disease (CVD) events. The objective of this study was to evaluate the efficacy and safety of the co-administration of fimasartan and rosuvastatin in patients with hypertension and hypercholesterolemia. METHODS: We con...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Pharmacol Toxicol
Autori principali: Rhee, Moo-Yong, Ahn, Taehoon, Chang, Kiyuk, Chae, Shung Chull, Yang, Tae-Hyun, Shim, Wan Joo, Kang, Tae Soo, Ryu, Jae-Kean, Nah, Deuk-Young, Park, Tae-Ho, Chae, In-Ho, Park, Seung Woo, Lee, Hae-Young, Tahk, Seung-Jea, Yoon, Young Won, Shim, Chi Young, Shin, Dong-Gu, Seo, Hong Seog, Lee, Sung Yun, Kim, Doo Il, Kwan, Jun, Joo, Seung-Jae, Jeong, Myung Ho, Jeong, Jin-Ok, Sung, Ki Chul, Kim, Seok Yeon, Kim, Sang-Hyun, Chun, Kook-Jin, Oh, Dong Joo
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217661/
https://ncbi.nlm.nih.gov/pubmed/28057081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-016-0112-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi